Published Date : 2025-May-05
By 2025, the global digital diabetes management market is experiencing explosive growth, projected to reach over $25.5 billion by 2025, driven by technological innovation, the prevalence of diabetes, and the demand for real-time, data-driven care. Digital solutions like continuous glucose monitors (CGMs), AI-powered health apps, and telemedicine platforms are reshaping diabetes care globally, especially across North America, Europe, and the Asia-Pacific.
By 2025, the global digital diabetes management market is forecasted to surpass $25.5 billion USD, driven by growing diabetes prevalence, increased adoption of mobile health (mHealth) apps, and the integration of AI in healthcare. The pandemic fast-tracked virtual care adoption, pushing companies to scale digital platforms for real-time glucose tracking, AI-based insulin dose calculation, and teleconsultation.
Digital Diabetes Management Market Size, Share & Trends Analysis Report By Type (Handheld Devices, Wearable Devices), By Product (Continuous blood glucose monitoring systems, Smart glucose meter, Smart insulin pumps, Smart insulin pens, Apps), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023-2031.
Key Data: According to a new report by IMIR Market Research.
2022 Market Value: USD 12.43 Billion
2031 Projected Value: USD 35.17 Billion
CAGR: 12.25% (2022–2031)
Region Highlight: North America holds the largest market share
The Digital Diabetes Management market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Digital Diabetes Management market.
Mobile App Integration: More than 70% of global diabetes patients are expected to use a mobile health app by 2025.
AI & Predictive Analytics: Companies like Glooko and One Drop are leveraging data for personalized coaching.
CGM Adoption: Dexcom and Abbott lead, with global CGM adoption projected to surpass 25.5 million users by 2025.
Company | Headquarters | Founded | Employees (2024) | Revenue (2024) |
Dexcom Inc. | San Diego, USA | 1999 | ~8,900 | $3.7 Billion |
Abbott Diabetes Care | Alameda, USA | 2004 | ~113,000 (total) | $5.6 Billion (Diabetes Care) |
Medtronic plc | Dublin, Ireland | 1949 | ~95,000 | $8.2 Billion (Diabetes Group) |
Roche Diabetes Care | Mannheim, Germany | 1896 | ~7,000 | ~$2.6 Billion |
Tandem Diabetes Care | San Diego, USA | 2006 | ~2,000 | $845 Million |
Insulet Corporation | Acton, USA | 2000 | ~3,000 | $1.5 Billion |
Glooko Inc. | Palo Alto, USA | 2010 | ~200 | N/A |
Ascensia Diabetes Care | Basel, Switzerland | 2016 | ~1700 | ~$1.1B |
mySugr (Roche) | Vienna, Austria | 2012 | ~100 | N/A (part of Roche) |
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
